National Pharmaceutical Pricing Authority

Type: Organization
Name: National Pharmaceutical Pricing Authority
First reported 6 hours ago - Updated 6 hours ago - 1 reports

USIBC Concludes Successful Pharmaceutical Mission to India

The U.S.-India Business Council (USIBC) has concluded its Pharmaceutical Executive Mission to Delhi, India. The delegation expressed its commitment to the Indian market, called for further dialogue with the government on issues related to pricing and ... [Published NextBillion.net - 6 hours ago]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

USIBC Concludes Successful Pharmaceutical Mission to India; Looks Forward to Continued Dialogue and Collaboration with the Government of India

The U.S.-India Business Council (USIBC) has concluded its PharmaceuticalExecutive Mission to Delhi, India. The delegation expressed itscommitment to the Indian market, called for further dialogue with thegovernment on issues related to pricing and intellectual ... [Published CEOWorld Magazine - Aug 27 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Making healthcare affordable

Much to the disappointment of the Indian pharmaceutical industry, the latest development on the bloc is the imposition of price ceilings on 108 non-scheduled formulations comprising anti-diabetics and drugs for cardiac ailments. The National Pharmaceutical ... [Published Livemint.com - Aug 27 2014]
First reported Aug 25 2014 - Updated Aug 26 2014 - 3 reports

NPPA grants price exemption for Torrent Pharma's FDC drug

Torrent Pharma has apparently become the first company to receive price exemption for a new drug from National Pharmaceutical Pricing Authority (NPPA) under the new drug pricing policy, which came into effect last year, according to a Business Standard. ... [Published Business Standard India - Aug 26 2014]
First reported Aug 24 2014 - Updated Aug 24 2014 - 1 reports

Pharma companies challenge price fixing

In response to pharmaceutical companies challenging the legality behind the National Pharmaceutical Pricing Authority (NPPA) fixing the price of 50 cardiovascular and diabetic drugs, civic societies have written a letter to the union health minister Dr ... [Published Asian Age - Aug 24 2014]
First reported Aug 23 2014 - Updated Aug 23 2014 - 1 reports

NPPA fixes/revises ceiling and retail prices of 56 formulation packs

The National Pharmaceutical Pricing Authority (NPPA) has fixed or revised the prices in respect of 56 formulation packs both ceiling and retail price packs under Drugs Prices Control Order (DPCO), 2013.The formulation packs whose prices have been fixed ... [Published PharmaBiz - Aug 23 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

Soaring medicine prices under Centre scrutiny

The Centre is examining the market prices of medicines for cancer, diabetes, heart diseases, tuberculosis and malaria besides prices of sera and vaccines with the objective of fixing their selling rates if their retail prices are too high for the consumers.The ... [Published Deccan Herald - Aug 14 2014]
First reported Aug 10 2014 - Updated Aug 11 2014 - 2 reports

Pharma industry for dialogue with govt on price control

PRESS TRUST OF INDIAMumbai, 10 AugustAfter failing to get a stay order from Delhi High Court on the latest round of drug price control order, the pharmaceutical industry has called for a dialogue with the regulators to resolve the row, saying such issues ... [Published The Statesman - Aug 10 2014]
First reported Aug 08 2014 - Updated Aug 09 2014 - 2 reports

SC notice to Pfizer on govt plea over Benadryl price cut

The Supreme Court on Friday issued a notice to pharma major Pfizer on a government plea over slashing the price of a popular cough syrup, Benadryl, a brand it no longer owns.It also stayed the Bombay High Court order that asked the drug price control ... [Published Financial Express - Aug 08 2014]
First reported Aug 05 2014 - Updated Aug 06 2014 - 2 reports

8/6/2014: Business: Developing online database to monitor drug prices: govt

NEW DELHI: The government is developing an online database system that will require pharmaceutical companies to submit information in order to enable the National Pharmaceutical Pricing Authority (NPPA) to control drug prices effectively. ... [Published Hindustan Times - Aug 06 2014]
First reported Aug 01 2014 - Updated Aug 01 2014 - 1 reports

Drug companies oppose India's move to slash prices of 50 drugs

India’s drug price regulator, the National Pharmaceutical Pricing Authority (NPPA), has announced that the prices of 50 cardiovascular and diabetes medicines will be reduced by 35%.The authority used... ... [Published British Medical Journal - Aug 01 2014]
First reported Aug 01 2014 - Updated Aug 01 2014 - 1 reports

Essential Medicines Prices

The order of the National Pharmaceutical Pricing Authority (NPPA) to cap the Maximum Retail Price (MRP) in respect of 108 non-scheduled formulations relating to diabetes and cardiovascular treatments has led to price reduction of these drugs ranging from ... [Published Press Information Bureau India - Aug 01 2014]

Quotes

The report says, "As many as 17 drugs were purchased at rates 0%-5% high, another 17 at 5%-20% high, 15 drugs at 20%-25% high, 12 at 50%-100% high, one at 100%-300% high and yet another at more than 300% high rate."
"We believe that any pharmaceutical policy should benefit patients and support sustainable access to innovative products and availability of quality medicines while at the same time building a robust and competitive pharmaceutical environment which encourages and promotes manufacturing, R&D and innovations as well as continued investment" Assocham national council on drugs and pharmaceutical council chairman Bhaskar Iyer and co-chairman Umang Chaturvedi said
...transgressed the mandate of DPCO 2013, which addressed pharmaceutical pricing based on the 'essentiality' criteria and clearly stated that the "intention of the policy is to bring essential medicines under price control and not to control the I ndian pharmaceutical industry" — a position that has been enunciated by the Department of Pharmaceuticals in an affidavit before the Supreme Court...
...It has been covered and debated in the media extensively. By the own announcement of the parties, this merger seeks to create the "Fifth Largest Global Specialty Generic Pharma Company in the world" , and also become the No.1 pharmaceutical company in India...

More Content

All (150) | News (150) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Drug buy: Now, health department panel indicts ... [Published Times of India - 30 mins ago]
USIBC Concludes Successful Pharmaceutical Missi... [Published NextBillion.net - 6 hours ago]
Drug price control order vitiates National Phar... [Published MyIris - 12 hours ago]
USIBC Concludes Successful Pharmaceutical Missi... [Published CEOWorld Magazine - Aug 27 2014]
Making healthcare affordable [Published Livemint.com - Aug 27 2014]
NPPA grants price exemption for Torrent Pharma'... [Published Business Standard India - Aug 26 2014]
Torrent Pharma gets price exemption for new FDC... [Published FirstWord Pharma - Aug 25 2014]
Torrent Pharma gets price exemption for new FDC... [Published Business Standard India - Aug 25 2014]
NPPA issues draft Internal Guidelines for deali... [Published PharmaBiz - Aug 25 2014]
Pharma companies challenge price fixing [Published Asian Age - Aug 24 2014]
NPPA fixes/revises ceiling and retail prices of... [Published PharmaBiz - Aug 23 2014]
Stocks in news: Eros, Zee Ent, Mangalore Chem, ... [Published Moneycontrol.com - Aug 20 2014]
DoP asks NPPA to revalidate data on Famotidine ... [Published PharmaBiz - Aug 20 2014]
Lupin local market thrust [Published Calcutta Telegraph - Aug 18 2014]
HOPE, SPELT OUT IN 72 WORDS [Published Calcutta Telegraph - Aug 15 2014]
Soaring medicine prices under Centre scrutiny [Published Deccan Herald - Aug 14 2014]
Random decisions in pharma pricing bad for Indi... [Published NextBillion.net - Aug 14 2014]
Is Sun-Ranbaxy Deal Heading For A Probe? [Published Businessworld India - Aug 13 2014]
Reckitt Benckiser questions price cap on condoms [Published Livemint.com - Aug 11 2014]
NPPA to allow cos to revise prices fixed by NPP... [Published PharmaBiz - Aug 11 2014]
Pharma industry for dialogue with govt on price... [Published The Statesman - Aug 10 2014]
Drug industry seeks talk with govt to resolve p... [Published Moneycontrol.com - Aug 10 2014]
Drug industry seeks dialogue with govt to resol... [Published Business Standard India - Aug 10 2014]
Union Health Ministry seeks synergy in fragment... [Published DNA India - Aug 09 2014]
SC notice to Pfizer on govt plea over Benadryl ... [Published Financial Express - Aug 08 2014]
Supreme Court notice to Pfizer on Benadryl syru... [Published Livemint.com - Aug 08 2014]
Hope govt consults us before deciding anything:... [Published Moneycontrol.com - Aug 08 2014]
Supreme Court stays HC order on Benadryl's pricing [Published Business Standard India - Aug 08 2014]
Biocon committed to list Syngene amid boost in ... [Published Moneycontrol.com - Aug 07 2014]
More drugs under DPCO can increase reliance on ... [Published Business Standard India - Aug 06 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.